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Abstract
The Third International Genomic Medicine Conference (3rd IGMC) was organised by the Centre of Excellence in
Genomic Medicine Research (CEGMR) at the King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia (KSA). This
conference is a continuation of a series of meetings, which began with the first International Genomic Medicine
Conference (1st IGMC, 2011) followed by the second International Genomic Medicine Conference (2nd IGMC, 2013).
The 3rd IGMC meeting presented as a timely opportunity to bring scientists from across the world to gather, discuss,
and exchange recent advances in the field of genomics and genetics in general as well as practical information on
using these new technologies in different basic and clinical applications. The meeting undoubtedly inspired young
male and female Saudi researchers, who attended the conference in large numbers, as evidenced by the
oversubscribed oral and poster presentations. The conference also witnessed the launch of the first content
for npj Genomic Medicine, a high quality new journal was established in partnership by CEGMR with Springer
Nature and published as part of the Nature Partner Journal series. Here, we present a brief summary report of
the 2-day meeting including highlights from the oral presentations, poster presentations, workshops, poster
prize-winners and comments from the distinguished scientists.
Introduction
Given the resounding success of the Second Inter-
national Genomic Medicine Conference (2nd IGMC) and
the publication of its outcome [1], the Center of
Excellence in Genomic Medicine Research (CEGMR)
continued its trend of open science discussion and orga-
nized the Third International Genomic Medicine Con-
ference (3rd IGMC, 30th November to 1st December
2015) (http://igmc-cegmr.org/Default.aspx) at the King
Faisal Convention Hall, King Abdulaziz University
(KAU). The 3rd IGMC provided a focused and in depth
view of the latest research findings relating to cancer,
genetics, genomic medicine, reproductive medicine,
ageing, metagenomics and metabolomics, personalized
genomics, biobanking, bioinformatics, along with many
other interesting topics. At least 500 leading international
researchers, renowned national scientists including those
from KAU dedicated scientific faculty, participated pro-
actively presenting their latest research findings. All the
recognized universities and research organizations in
Saudi Arabia including CEGMR, Center of Innovation in
Personalized Medicine (CIPM), King Fahd Medical
Research Center (KFMRC) and King Abdulaziz City for
Science and Technology (KACST) participated. The
following countries were represented: Canada, Egypt,
Germany, Japan, Qatar, Spain, Switzerland, Tunisia,
Turkey, United Kingdom (UK), and United States of
America (USA).
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One of the major events of the meeting was the
announcement and launch of the first issue of the npj
Genomic Medicine, a journal that was established by
CEGMR in partnership with the Nature Publishing
Group (NPG). In addition, a significant number of pri-
vate companies attended the conference and took advan-
tage of the meeting to present their state-of-the-art
products, and services supporting genome research.
Workshops (for all participants and others for local
training endeavors) were organized over 3 days following
the 2-day symposium. Here, we report the overall events
and activities of the meeting including oral presenta-
tions, poster sessions, workshops, poster prize winners
and comments from highly distinguished guest speakers
about the meeting.
3rd IGMC 1st day, opening and welcoming session
On 30th of November, the conference began symbolically
with an opening ceremony and welcome reception pro-
ceeding with the recitation of Holy Quran. The session
was chaired by Professor Adeel Chaudhary, Deputy Dir-
ector at CEGMR and Vice Dean of the Faculty of Ap-
plied Medical Sciences, KAU. On the stage, the Chief
Guest, His Highness Vice President Professor Adnan
Zahid and the Director of CEGMR, Professor Mohammed
Al-Qahtani were seated to accord the occasion. A large
number of foreign delegates, guests of honor, scientists,
faculty and participants from a variety of institutes were in
attendance. Professor Mohammed Al-Qahtani, gave a wel-
come address (Table 1) and recalled the interdepartmen-
tal, regional and international collaborations that have
been fostered since the inception of the center and how
notable progress has been achieved and sustained as a re-
sult of these collaborations. As a mark of respect to the
University, Professor Al-Qahtani presented a memento to
Professor Adnan Zahid who obliged by accepting it. Pro-
fessor Al-Qahtani presented Dr. Abdulaziz Al-Swailem,
Vice President, King Abdulaziz City for Science and Tech-
nology (KACST), Riyadh, KSA who then delivered an
important speech in which he briefed the attendees on the
launch of the second phase of the next 5 year KACST re-
search plan (Maarifah Two) (Table 1). In addition, further
funding opportunities were presented by Dr. Omar El-
Farouk, the Director of Qatar National Research Fund
(QNRF), Qatar Foundation, Doha, Qatar. The attendees
found this talk, in particular, a golden opportunity to apply
for funding outside Saudi Arabia, which would be an
excellent vehicle for networking amongst researchers
working in Gulf countries.
The 3rd IGMC meeting, for the first time, invited a se-
nior member (Dr. Nazeeh Al-Othmany) from the Saudi
Food and Drug Administration (SFDA) who presented a
detailed view of the workings of the organization, its
aims and how all members of the SFDA organization are
continuously trying to help and facilitate the mission of
scientists at the research centers within Saudi Arabia.
The welcoming session ended with a presentation by Dr.
Magdalena Skipper, the npj Executive Editor, NPG, UK
who presented the model of the partnership between the
NPG and CEGMR, which has led to establishment of
the first npj journal in the Middle East, npj Genomic Medi-
cine (http://www.nature.com/npjgenmed/). This fruitful
partnership between NPG and KAU has led to establish-
ment of a second npj journal, npj Climate and Atmospheric
Science, http://www.nature.com/npjclimatsci/. Later, the
Editor-in-Chief Dr. Stephen Scherer of npj Genomic
Medicine announced the launch of the first issue of the
journal. After Dr. Skipper’s talk the proceedings of the
conference were declared open and all attendees settled
to scientific business.
3rd IGMC 1st day, session I: genomics of cancer, aging and
complex diseases
The second session on Day 1 was dedicated mainly to
“Genomics of Cancer, Ageing and Complex Diseases”
(Table 2). This session was chaired by the distinguished
Professor Angel Carracedo, a prominent clinician scien-
tist affiliated with KAU, Professor Adnan Merdad
(School of Medicine, KAU) and Professor Abdelbaset
Buhmeida (CEGMR, KAU). The first talk was the keynote
lecture given by Professor Jerry W. Shay from the Depart-
ment of Cell Biology, University of Texas Southwestern
Medical Center, Dallas, USA on “Ageing and Cancer: Are
Table 1 3rd IGMC 1st Day oral talks, opening and welcoming
session
Session I
Opening and welcoming session
Chairperson: Professor Adeel Chaudhary
09:00–09:15 Professor Mohammed Al-Qahtani: Director of Centre
of Excellence in Genomic Medicine Research, King
Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
Title: Welcoming and Opening the 3rd IGMC
09:15–09:25 Professor Abdurrahman Alyoubi: President of
King Abdulaziz University, Jeddah, KSA
Title: KAU and its Role in Supporting the IGMC
09:25–09:35 Dr. Abdulaziz Al-Swailem: Vice President, King Abdulaziz
City for Science and Technology, Riyadh, KSA
Title: KACST and Prospects of Research in Saudi Arabia,
Maarifah-2
09:35–09:50 Dr. Omar El Farouk Boukhris: Director, Qatar National
Research Fund, Qatar Foundation, Doha, Qatar
Title: Funding Opportunities at QNRF
09:50–10:05 Dr. Nazeeh Al-Othmany: Saudi FDA, KSA
Title: Helping Research in Saudi Arabia
10:05–10:20 Dr. Magdalena Skipper: npj Executive Editor, Nature
Publishing Group, United Kingdom
Title: CEGMR & Nature Partnership
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Telomeres and Telomerase the Connection?” Professor
Shay discussed the regulation over long distances of genes
by telomere length. He elucidated his group’s discovery
using 3D Co-FISH and a modified method of chromosome
capture followed by high-throughput sequencing (Hi-C) to
identify a significant number of genes within the first
10 Mb distal to the telomeres on many chromosomes regu-
lated by telomere length. Professor Shay showed that the
human telomerase reverse transcriptase (TERT) locus was
also linked with looped chromatin structures in cells with
long telomeres but was reduced in cells with shorter telo-
meres. He termed telomere length dependent regulation of
gene expression as telomere position effects over long dis-
tances (TPE-OLD). He also showed that gene expression
was regulated by telomere length long before telomeres be-
come short enough to initiate a DNA damage response.
These findings demonstrated a novel function for telomeres
and also suggested a new mechanism for how progressive
telomere shortening might affect human age associated
disease initiation and progression.
The keynote lecture was followed by a presentation by
Professor Stephen Scherer from the Centre for Applied
Genomics, Hospital for Sick Children and University of
Toronto, Canada on “Genomic basis for autism spectrum
and related disorders”. He explained the substantial con-
tribution of non-coding variants to the aetiology of autism
spectrum disorders (ASD) and highlighted the significance
of using whole genome sequencing (WGS) for compre-
hensive genetic analyses. A novel observation shared
was an increased frequency of de novo mutations near
to de novo copy number variations residing on the ma-
ternal chromosome. He also discussed how to integrate
epigenomic data with whole genome sequence data and
interpret complex data through clustering approaches.
He further emphasized the importance of performing
WGS of 10,000 individuals with ASD and their family
members and applying this data to diagnostic and drug
treatment design [2].
Professor Albert Fornace from the Lombardi Compre-
hensive Cancer Center, Georgetown University, USA
then spoke on “Integration of metagenomics and meta-
bolomics in gut microbiome research”. Professor For-
nace presented his research group’s various discoveries
using metagenomics and metabolomics strategies to
understand the correlative nature of the microbe/host
co-metabolism to distinguish the regulatory functions of
microbiota in preserving the health of the host. He
further explained the potential of host/microbial inter-
action studies to define causality, response to treat-
ment, risk prediction, and keystone species to exploit
as probiotics in diseases such as inflammatory bowel
disease (IBD) or colonic inflammation (colitis) trig-
gered by immune-radiotherapy.
Professor Nobutaka Hirokawa from the Departments
of Cell Biology and Anatomy, and Molecular Structure
and Dynamics, University of Tokyo, Japan presented in-
teresting talk titled “KIF2A regulates postnatal axons
and its deficiency causes malformation of cortical devel-
opment and epilepsy”. He presented his findings on the
importance of Kinesin-13 super family protein 2A
(KIF2A), an ATP-dependent microtubule destabilizer, in
the development of precise neuronal circuits, prenatal
cell survival, migration and the elongation of axons. He
further described various studies to decipher the role of
KIF2A in neuronal development using tamoxifen-inducible
conditional KIF2A knockout mice. He showed that the loss
of KIF2A led to hippocampal sclerosis, dentate mossy
fiber (MF) sprouting, and recurrent excitatory circuits
resembling but different from temporal lobe (TLE) and
these phenotypes developed without excitation. More
importantly, he showed that the conditional KIF2A
granule cells displayed failed axon/dendrite differenti-
ation, and developed multiple short axons throughout
the entire molecular layer.
Then Dr. Deema Hussain from KFMRC, KAU gave a
presentation on “A unique integrated system to discern
Table 2 3rd IGMC, 1st Day, Session II
Session II
Genomics of cancer, aging and complex diseases
Chairpersons: Professor Adnan Merdad, Professor Angel Carracedo and
Professor Abdelbaset Buhmeida
10:40–11:20 Keynote Speaker, Professor Jerry W. Shay: Director, Cancer
Biology, Department of Cell Biology, University of Texas
Southwestern Medical Center, Dallas, USA
Title: Aging and Cancer: Are Telomeres and Telomerase
the Connection?
11:20–11:45 Professor Albert J. Fornace Jr.: Director, Waters Center of
Innovation for Metabolomics; Molecular Cancer Research
Chair, Lombardi Comprehensive Cancer Center; Georgetown
University, USA
Title: Integration of Metagenomics and Metabolomics in
Gut Microbiome Research
11:45–12:15 Dr. Deema Hussein: King Fahd Medical Research Centre,
King Abdulaziz University, KSA
Title: A Unique Integrated System to Discern Pathogenesis
of Central Nervous System Tumors
12:15–12:35 Professor Stephen Scherer: Director of the McLaughlin
Centre and Centre for Applied Genomics, Hospital for Sick
Children and University of Toronto, Toronto, Canada
Title: A Genomic Basis for Autism Spectrum and Related
Disorders
12:35–12:50 Professor Nobutaka Hirokawa: Departments of Cell Biology
and Anatomy, Graduate School of Medicine, University of
Tokyo, Japan
Title: KIF2A Regulates Postnatal Axons and its Deficiency
causes Malformation of Cortical Development and Epilepsy
12:50–13:05 Dr. Heba Alkhattabi: Centre of Excellence in Genomic
Medicine Research, KAU, Jeddah, Saudi Arabia
Title: RPL27A, a Novel Target for miR-595 and its Contribution
to Myelopoiesis via Ribosomal Dysgenesis
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pathogenesis of central nervous system tumours”. Her
presentation focused on the establishment of a unique
integrated system to facilitate the analysis of multiple
bio-parameters of distinct central nervous system tu-
mours (CNST) such as meningiomas, astrocytomas,
oligodendrogliomas, medulloblastomas and glioblast-
omas. She explained about generating cell lines from
CNST for further genetic, biochemical, cytological and
pharmacological analysis. She also elaborated further on
the importance of gene expression profiling of uncul-
tured tumour samples to enable identification of several
novel prognostic markers for meningiomas, including
the recently associated cancer stem cell marker called
anterior gradient protein 2 homolog (AGR-2). Dr.
Deema concluded that the integrated analysis approach
was essential for the development of safe, efficacious and
potent targeted therapeutic modalities for CNST.
The final presentation of the second session on Day 1
was delivered by Dr. Heba Alkhattabi from CEGMR on
“RPL27A, a novel target for miR-595 and its contribu-
tion to myelopoiesis via ribosomal dysgenesis”. She dis-
cussed the identification of several targets for miR-595
including a large ribosomal subunit RPL27A using a
novel method. Dr. Alkhattabi explained that the down
regulation of RPL27A triggered p53 activation, apoptosis
and inhibited proliferation. More significantly, she
showed that p53-independent effects were observed sec-
ondarily to a reduction in the ribosome subunit 60s with
associated ribosome dysgenesis. In addition, RPL27A
overexpression did not influence the p53 mRNA levels
but enhanced proliferation. RPL27A knockdown in nor-
mal CD34+ cells specially inhibited erythroid prolifera-
tion and differentiation. Dr. Alkhattabi concluded that
haploinsufficiency of miR-595 in Myelodysplastic Syn-
dromes (MDS) patients with - 7/del 7q may contribute
to disease pathogenesis via RPL27A modulation since
miR-595 was significantly down regulated in these pa-
tients with −7/-7q anomalies.
The final scientific session of the first day (Session III)
was on "Genomics applications towards personalized
medicine" (Table 3) with all presentations focused on the
theme of how the latest advancements in genomics
could translate to personalization, also referred to as the
precision or personalized medicine. Professor Emma-
nouil Dermitzakis from the Department of Genetic
Medicine and Development, University of Geneva Med-
ical School, Switzerland highlighted the genotype-tissue
expression (GTEx) project, where multiple 'non-dis-
eased' tissue samples collected from recently deceased
human donors could be used for analysis across tissues
and individuals. The patterns of transcriptome variations
across individuals and tissues and their association with
human phenotypes can be analyzed using GTEx data.
Furthermore, quantification of gene expression by RNA-
sequencing on GTEx samples had high concordance
with microarray based quantification, thus indicating the
value of the samples. Recent advances in tumor biology
will enable personalization of cancer therapeutics with
reliance on information from the International Cancer
Genome Consortium (ICGC), The Cancer Genome Atlas
(TCGA) and the Cancer Genome Project (CGP) as well
as the understanding of the oncogenic drivers, the
genes involved in disease progression, the identifica-
tion of biomarkers and the development of drugs for
specific targets.
Along similar lines, Professor Anna Goodeve from
Sheffield Diagnostic Genetic Service, Sheffield Children's
NHS Foundation Trust, UK, shared her experience on
how next generation sequencing (NGS) and gene panels
have extended diagnostic capability in analyzing blood
related disorders. The haemostasis and platelet gene
panel which included 13 genes and another panel con-
sisting of 16 genes that are currently known to be associ-
ated with Fanconi's anaemia (FA) were sequenced using
the Illumina MiSeq or HiSeq. Dr. Goodeve’s results re-
vealed that the haemostasis and platelet panel enabled
identification of pathogenic candidate mutations in
62 % of the patients. The FA panel led to the identifi-
cation of biallelic mutations (33 %), heterozygous mu-
tations (13 %), homozygous mutations (13 %), other
gene mutations (7 %) and no mutations (33 %). She
concluded that the use of NGS provides a single la-
boratory workflow for analysis of gene panels for dif-
ferent disorders and considerably reduces time to
achieve a definitive diagnosis.
In the final presentation of this session, Dr. Ashraf
Dallol, from the CIPM/CEGMR at KAU, explained the
usefulness of targeted sequencing of cancer mutational
hotspots in combination with the Ion Torrent Personal
Genome Platform in a cohort of colorectal cancer (CRC)
Table 3 3rd IGMC, 1st Day, Session III: Genomics applications
towards personalized medicine
Session III
Genomics applications towards personalized medicine
Chairpersons: Professor Jerry Shay, Professor Jaudah Al-Maghrabi and Dr.
Muhammad Abu-Elmagd
14:35–14:55 Professor Emmanouil Dermitzakis: Department of Genetic
Medicine and Development, University of Geneva Medical
School, Switzerland
Title: Population and Personalized Genomics to Understand
Disease and Personal Biology
14:55–15:15 Professor Anne Goodeve: Department of Cardiovascular
Science, University of Sheffield, Medical School, UK
Title: Experience of Next-Generation DNA Sequence Analysis
in a UK Genetics Laboratory
15:15–15:45 Dr. Ashraf Dallol: Centre of Excellence in Genomic Medicine
Research and CIPM, KAU, Jeddah, KSA
Title: Genomics of Colon Cancer From Saudi Arabia
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cases from Saudi Arabia. CRC is a heterogeneous disease
influenced by genetic and epigenetic variations acting as
passengers or drivers of the tumor. Dr. Dallol showed
that analysis of the mutational status of 2,800 catalogued
somatic mutations in cancer (COSMIC) mutations of
50 oncogenes and tumor suppressor genes in CRC
would enable understanding the genetic background
for this cohort and thus pave the way to precision
medicine (PM).
3rd IGMC 2nd day, session I, biobanking in the
post-genomic era
Since the completion of the Human Genome Project in
2003, a significant increase in the number of Biobanks
(also called Biorepositories including their improved de-
sign, scale and governance) has been observed world-
wide. The main aim of establishing these banks was to
support effective genomic research and personalized
healthcare. Nowadays, Biobanks are considered as the
main core around which OMICs research and advanced
clinical applications are carried out to drive PM [3].
However, a major PM challenge research community
currently facing is the need for a large scale of high-
quality and fully annotated bio- specimens. To address
such challenge, thousands of biobanks in developed
countries have been established and are currently work-
ing towards harmonizing their practices internationally
[4]. However, this big number of biobanks established in
the developing countries needs to establish crucial re-
sources to overcome lack of knowledge, awareness, and
practice (KAP) in addition to other technical, oper-
ational, ethical and regulatory challenges.
Therefore, the 3rd IGMC “Biobanking in the Post-
Genomic Era” session (Table 4) was aimed at raising the
level of knowledge and awareness of the research com-
munity and public within Saudi Arabia, the Gulf region
and at the international level in order to draw attention
to the importance of this critical resource. During the
session, the quantity and quality of biospecimens were
highlighted by both international (Professor Jim Vaught)
and national (Professor Abdelbaset Buhmeida) speakers.
They demonstrated that this issue is fundamental in
order to produce effective diagnostic tools and tailor
customized drugs to enhance the clinical service offered
to patients. The need for additional high quality and
fully annotated biospecimens processed using Standard
Operating Procedures (SOPs) was also highlighted as
one of the top priorities of biomedical research in order
to deliver more accurate downstream diagnostic test re-
sults. Dr. Ibrahim Alabdulkareem from the National
Guard Health Affairs, Riyadh, KSA and Professor Jaudah
Al-Maghrabi from Pathology Department, College of
Medicine, KAU, Jeddah, KSA strongly emphasized this
issue. The Biobank session witnessed extensive discussion
from the audience and this was marked by motivation
from both patients who attended this session to donate
their biospecimens and scientists who requested support
and guidelines from CEGMR biobanks.
IGMC 2nd day, session II: bioinformatics applications in
genomic medicine
The continuous development of new OMICs technolo-
gies has led to generation of unprecedented large data
sets. Handling and analysis of these OMICs data to
extract meaningful and clinically actionable targets are
serious challenges [5]. Additional approaches are re-
quired to achieve integrative analysis of heterogeneous
data. That is to tailor meaningful predictions and associ-
ations of the data in order to better understand the
molecular pathology of diseases to improve targeted
treatment [6, 7]. With the integration of OMICs in mod-
ern healthcare, the 3rd IGMC dedicated a session to
“Bioinformatics applications in genomic medicine”
(Table 5). Given the complexity of cancer, the session
started with a presentation by Professor Sudhir Kumar,
Department of Biology, Temple University, Philadelphia,
USA, who showed an analysis of cancer heterogeneity
assessed from an evolutionary prospect and demonstrated
its use in tracing the origins, patterns, and evolutionary re-
lationships of homologous sequences of cancer clones
(clonotypes) to overcome the hurdle of cancer heterogen-
eity for diagnosis, prognosis and therapeutics [8].
Moving from the genome-wide association study
(GWAS) scale to target specific rare and disease-specific
variations was another major focus of the conference
Table 4 3rd IGMC, 2nd day, Session I: Biobanking in the post-
genomic era
2nd day, Session I
Biobanking in the post-genomic era
Chairpersons: Professor Stephen Scherer, Dr. Mourad Assidi and Dr.
Farid Ahmed
09:00–09:30 Professor Jim Vaught: President, ISBER, Editor-in-Chief
Biopreservation and Biobanking, International Prevention
Research Institute, Maryland, USA
Title: Current Perspectives in International Biobanking
09:30–09:45 Dr. Ibrahim Alabdulkareem: Chairman of Medical Genomic
Research Department, King Abdullah International Medical
Research Center, King Abdulaziz Medical City, National
Guard Health Affairs, Riyadh, KSA
Title: Saudi Biobanks: Importance, Implications and
Opportunities
09:45–10:00 Professor Abdelbaset Buhmeida: Centre of Excellence in
Genomic Medicine Research, KAU, Jeddah, KSA
Title: The CEGMR Biobanking Unit: Achievements, Challenges
and Future Plans
10:00–10:15 Professor Jaudah Al-Maghrabi: Pathology Department, College
of Medicine, KAU, Jeddah, KSA
Title: Tissue Microarray Technique: A powerful Adjunct Tool
for Molecular Profiling of Solid tumors
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delivered by Professor Angel Carracedo from Legal
Medicine Santiago de Compostela University, Spain. He
showed that moving from GWAS-driven associations to
causality is a key turning point towards personalized
medicine. However, a further filtering step of the large
number of associations revealed by GWAS with reduced
heritability is necessary to identify causality or susceptibil-
ity targets. Professor Carracedo suggested new targeted
re-sequencing of GWAS association targets in order to re-
fine both the scale and mapping of the genomic hits.
These identified hits would provide clues to decrypting
the molecular pathways.
Professor Carracedo’s talk was followed by that of
Professor Hossam Faheem from Fujitsu Technology
Solutions International, Japan who showed that several
factors including computer science, medical informatics,
Biobanking LIMS (Laboratory Information Management
System), bioinformatics, biostatistics and OMICs data-
sets should be joined to tailor a clinical integrative ana-
lysis workflow of heterogeneous datasets in order to
drive the current transition from OMICs-based science
to OMICs-based healthcare. He showed that advanced
computational tools such as the supercomputing facil-
ities with superior memory to accommodate parallel and
computationally intensive applications’ needs offer excel-
lent solution which are now implemented at KAU
(named as AZIZ supercomputer facility).
The bioinformatics session ended with a presentation
by Dr Sajjad Kareem from CEGMR who highlighted de-
veloping a new web application called E-GRASP which
allows: (i) SNPs view including information about
SNPid, PMID, P-value, chromosome, position, number
of studies and phenotypes for each SNPs, (ii) studying
view; which explains unique SNPs replication in each
studies and phenotypes and (iii) evolutionary view which
describes evolutionary information including E-value for
SNP phenotype association, E-rank of the evolutionary
rate and time span of the position retrieved from the “E-
rank Web Server” for each SNP. Dr. Karim concluded
that E-GRASP is a more representative database with
additional information of SNPs replication and evolu-
tionary scores, facilitating the comprehensive qualitative
and quantitative analysis.
IGMC 2nd day, session III: reproductive medicine in the
21st century
The investigation of disease aetiologies requires a com-
plex and multidimensional approach. Sufficient under-
standing of these diseases origins and susceptibility is an
important prerequisite. Thus, investigation of germline
genomic instability (mutations and epi-mutations) and
its role in disease heritability and/or susceptibility during
reproductive and embryonic phase will provide clues
about diseases’ origin and relevant causative genomic
variations. The Reproductive Medicine in the 21st Cen-
tury Session at the 3rd IGMC was dedicated to highlight
the revolution in reproductive and developmental medi-
cine due to the OMICs-based application that can offer
successful and cost-effective solutions.
Dr. Aisha Elaimi from the CEGMR/KAU (Table 6)
highlighted how an experimental animal model system,
such as the Embryoscope™, can be used to assess the de-
velopmental stages of an embryo directly from two cell
to blastocyst stages in the presence or absence of
Table 5 2nd day of the 3rd IGMC, Bioinformatics applications in
genomic medicine
Session II
Bioinformatics applications in genomic medicine
Chairpersons: Professor Jim Vaught and Dr. Ashraf Dallol
11:35–11:55 Professor Sudhir Kumar: Director, Institute for Genomics
and Evolutionary Medicine, Carnell Professor, Department
of Biology, Temple University, Philadelphia, USA
Title: Phylomedicine of Tumors
11:55–12:15 Professor Angel Carracedo: Director of the Galician
Foundation of Genomic Medicine, Professor of Legal
Medicine Santiago de Compostela University, Spain
Title: Cancer Genetics: From GWAS to the Discovery of
Rare Variation
12:15–12:35 Professor Hossam Faheem: Computer Systems International
Consultant; HPC Project Manager, Fujitsu Technology
Solutions International
Title: The Supercomputer Facility “AZIZ” at KAU: Utility and
Future Prospects
12:35–12:50 Dr. Sajjad Karim: Centre of Excellence in Genomic Medicine
Research, KAU, Jeddah, KSA
Title: E-GRASP: A Resource for Exploring Outcomes of the
Genome-Wide Association Studies through the Lens of
Interspecific Evolutionary History
Table 6 2nd day of the 3rd IGMC, Reproductive medicine in the
21st century
Session III
Reproductive medicine in the 21st century
Chairpersons: Professor Taha Abo Almagd and Dr. Gauthaman Kalamegam
14:20–14:40 Dr. Aisha Elaimi: Center of Innovation in Personalized
Medicine, King Abdulaziz University, Jeddah, KSA
Title: The effect of GM-CSF on murine embryo development,
aneuploidy, DNA fragmentation and morphokinetic
parameters analyzed using Embryo Scope
14:40–15:00 Dr. Serdar Coskun: King Faisal Specialist Hospital &
Research Center, Riyadh, KSA
Title: A New Look to Reproductive Medicine in The Era of
Genomics
15:00–15:20 Professor Ashok Agarwal: Director, Center for Reproductive
Medicine, The Cleveland Clinic, Cleveland, USA
Title: New Research into the Causes of Male Infertility
15:20–15:40 Professor Eberhard Nieschlag: Emeritus Professor, Center
for Reproductive Medicine and Andrology, University
Hospital of Muenster, Germany
Title: The Klinefelter Syndrome: Recent Progress
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pharmacological agents. Such an experimental system
can be utilized to have a better understanding of the
impact of blastulation rate and aneuploidy or DNA frag-
mentation, which in turn can lead to personalized thera-
peutic applications.
Dr. Serdar Coskun from King Faisal Specialist Hospital
and Research Center, Riyadh, KSA addressed the issue of
the OMICs scale applications and their impact in preim-
plantation genetic testing (PGT), where only one or a
few cells are available for genomic analysis. He showed
that the development of single cell whole genome ampli-
fication (scWGA) technologies enabled obtaining suffi-
cient high-quality DNA from the initial minute starting
material [9]. Dr. Coskun showed that PGT allowed the
birth of a healthy baby who can potentially donate either
the cord blood or haematopoietic stem cells to treat
another ill patient.
Professor Ashok Agarwal, Center for Reproductive
Medicine, The Cleveland Clinic, Cleveland, USA, fo-
cused his presentation on addressing new research into
the causes of male infertility including proteomics which
is the new frontier of research in male infertility as it
allows the identification of numerous sperm-specific
proteins. Prof. Agarwal concluded that proteomics pro-
vides a greater understanding of protein functions in-
volved in sperm processes such as motility, capacitation,
acrosome reaction and fertilization.
The reproductive medicine session wrapped up with a
presentation by Professor Eberhard Nieschlag, Center
for Reproductive Medicine and Andrology, University
Hospital of Muenster, Germany, who focused on the
Klinefelter Syndrome (KS) and its relationship with in-
fertility. He showed that the incidence of KS in the gen-
eral male population is 1:500 and among 23,000 patients
of the Center for Reproductive Medicine and Andrology
at the University of Muenster, Germany is 1:52, whereas
in Saudi Arabia the incidence is 1:11 in selected patients
with azoospermia or sperm counts <5 mill/ml. Professor
Nieschlag’s presentation drew the attention to the ser-
ious impacts of the KS on Saudi infertility patients.
Workshops
The scientific sessions of the 3rd IGMC were accompan-
ied by eight workshops. These workshops offered the
opportunity for local researchers to enhance their prac-
tical knowledge as well as to introduce the novice to the
wide array of applications and cutting edge technologies
available to researchers. The practical IGMC workshops
covered a range of areas such as molecular cytogenetics
in medicine, molecular genetics, flow cytometry in on-
cology, bioinformatics, high throughput DNA sequen-
cing and microarrays. One additional workshop was
introduced for the first time in the IGMC, the publica-
tion workshop, which was very well-received by the
participants. Overall, the high demand for such wide
range of training was demonstrated by the large number
of applicants (n = 48) enrolling in the workshops. The
venue for training was provided by CEGMR at KAU and
many of the workshops were overseen and delivered by
highly distinguished, international faculty who partici-
pated in the IGMC conference in a number of capacities.
The success of the workshops program demonstrated
the desire and enthusiasm of many local researchers to
extend their knowledge in different fields and further
develop their professional capabilities.
3rd IGMC young scientists’ poster winners
The conference organizers recognized the importance of
motivating young scientists and hence offered prizes for
the best poster presentations. Nearly two hundred post-
ers were displayed covering a wide range of research
topics. A selected committee critically assessed the dis-
plays; posed questions to the participants; evaluate their
explanations on the subject; and on the basis of a set of
criteria, selected for the three top poster presentations.
Each winner received a certificate and a monetary award.
The first prize (5000 Saudi Riyals, SR) was awarded to
Olfat Al-Harazi from the Department of Biostatistics,
Epidemiology and Scientific Computing, King Faisal S-
pecialist Hospital and Research Centre, Riyadh, KSA
(Poster number 30) titled ‘’Breast Cancer Incidence and
Genomic Signature in Young and Old Women in Saudi
Arabia and Western Countries‘’. The second prize (4000
SR) went to Nezar Al-hebshi, Department of Preventive
Dentistry, College of Dentistry, Jazan University, Jazan,
KSA (Poster number 23) titled ‘’Mutational landscape of
Arabian snuff-associated oral squamous cell carcinoma‘’.
The third prize (SR 3000) was earned by Nada Salem
from CEGMR/KAU, KSA (Poster number 105) titled:
‘’Integrated use of evolutionary information in GWAS
reveals important SNPs in Asthma‘’.
3rd IGMC scientific committee members
This committee consisted of nine members whose role
was to carefully review the abstracts, make final decisions
on the acceptance or rejection of submitted abstracts, and
to decide which abstracts would be presented either as a
poster or as an oral presentation. The members of the sci-
entific committee are as follows:
1. Dr. Muhammad Abu-Elmagd
2. Dr. Ashraf Dallol
3. Professor Jerry W. Shay
4. Dr. Gauthaman Kalamegam
5. Dr. Mourad Assidi
6. Professor Abdelbaset Buhmeida
7. Dr. Farid Ahmed
8. Professor Stephen W. Scherer
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9. Professor Bruce Budowle
10.Dr. Hans H. Schulten
Editing the 3rd IGMC abstracts’ and articles’ supplements
was led by Dr. Muhammad Abu-Elmagd who worked as
the editor of both supplements. The 3rd IGMC abstracts’
supplement was published in BMC Genomics (https://
bmcgenomics.biomedcentral.com/articles/supplements/
volume-17-supplement-6). The articles' supplement con-
taining 16 peer-reviewed articles was published in a number
of BMC journals including BMC Genomics, BMC Medical
Genetics, BMC Cancer and BMC Structural Biology. The
final decision on accepting and rejecting manuscripts was
made by the Executive Editor of BMC Genomics.
Thoughts about the 3rd IGMC by eminent scientists
1. Guest keynote speaker Professor Jerry W. Shay:
‘’This was by far the most successful International
Genomic Medicine Conference that was held in
Jeddah, November 2015. There was a very large
number of attendees that led to many discussions
about science enabling many new collaborations.
The invited speakers were excellent, covering
diverse areas of genomics and human disease. The
organization of the meeting was simply outstanding.
Everything worked from registration, the overall
program and most importantly the poster sessions.
As one of the judges of the poster sessions, I had
many conversations with young scientists. Their
excitement about their work was contagious and
will certainly have a future positive impact for
science in the Kingdom of Saudi Arabia‘’.
2. The Director of the Centre for Applied Genomics,
The Hospital for Sick Children and The Director
of McLaughlin Centre for Molecular Medicine,
University of Toronto, Canada, Professor Stephen
Scherer: ‘’The meeting was memorable because all
of the discussions were grounded in science and in
data quality including interpretation of results. The
session on Biobanking was very important since this
can be done 'right' or it can be done 'wrong' and
there needs to be scholarly discussion early on in
decision-making. Perhaps, most importantly, I was
energized by the excitement of the younger people
participating at the meeting including many who
traveled from remote regions of the Kingdom. There
were many good lessons to be learned from the locals,
national, and international participants‘’.
3. The Director of the American Center for Reproductive
Medicine, Cleveland Clinic, USA, Professor Ashok
Agarwal: ‘’I am pleased to share my impressions of the
Third International Genomics Medicine Conference
organized by the Center for Excellence in Genomic
Medicine Research at King Abdulaziz University,
Jeddah, Saudi Arabia in November 2015. The meeting
was nicely organized in a pleasant venue, it had a large
number of attendees and a galaxy of highly recognized
speakers from many parts of the world. The keynote
lectures went really well; there was lively discussion
after these talks. The presentation by local team of
researchers was of high quality and a good indicator of
future developments in the field of genomic medicine.
I came back with good memories of the excellent
scientific discourse, opportunity to meet and listen
to both local and international scientists and most
importantly the warm hospitality of the local
organizing committee‘’.
Conclusions
The 3rd International Genomic Medicine Centre set a
stage for the next round of planning and scientific in-
vestment in the area of individualized (precision) medi-
cine in Saudi Arabia [10]. The active participation of
female Saudi scientists was unprecedented. The confer-
ence witnessed the launch of the first issue of npj Genomic
Medicine, a journal CEGMR/KAU has established in part-
nership with the Nature Publishing Group (NPG) that
promises to expand publishing options in the Middle East
and around the world. The conference workshops offered
extensive training to the participants in a wide range of
genomics tools and approaches. The take away message
from most talks was that studying the population struc-
ture and health challenges confronting Saudi Arabia and
by openly publishing the results would not only help
people in this region, but also provide lessons for other
countries around the world.
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